Business Context and Reporting Period
This Form 8-K is a current report filed by iBio, Inc. on October 8, 2020. The filing announces the scheduling of the Company's 2020 Annual Meeting of Stockholders and establishes specific deadlines for shareholder proposals.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
The primary material change reported is the advancement of the 2020 Annual Meeting of Stockholders to December 9, 2020. This date is more than 20 days prior to the anniversary of the 2019 Annual Meeting, triggering specific procedural requirements under the Company's Bylaws and SEC rules regarding shareholder proposals.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: December 9, 2020.
- Record Date: October 27, 2020 (close of business).
- Shareholder Proposal Deadline (Rule 14a-8): October 21, 2020 (close of business) for proposals to be included in proxy materials.
- Bylaw Notice Deadline: Proposals intended for inclusion under the Company's Bylaws must be received by the later of 90 days before the meeting or 10 days after the public announcement of the meeting date.
- Submission Address: Corporate Secretary, 8800 HSC Parkway, Bryan, Texas 77807.
Key Facts for Investor Verification
- Verify the record date of October 27, 2020, to determine eligibility to vote at the December 9, 2020 meeting.
- Confirm the October 21, 2020 deadline for submitting Rule 14a-8 proposals for inclusion in the proxy statement.
- Note that the meeting date change requires strict adherence to the Company's Bylaws for any stockholder nominations or proposals.